Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts
Titel:
Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts
Auteur:
van der Helm, L.H. Veeger, N.J.G.M. Kooy, M. van Marwijk Beeker, A. de Weerdt, O. de Groot, M. Alhan, C. Hoogendoorn, M. Laterveer, L. van de Loosdrecht, A.A. Koedam, J. Vellenga, E. Huls, G.